Inebilizumab
Uplizna, Trogarzo (inebilizumab) is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against B-lymphocyte antigen CD19.
| Trade Name | Uplizna, Trogarzo |
|---|---|
| Common Name | Inebilizumab |
| Indication | neuromyelitis optica |
| Drug Class | Monoclonal antibodies: humanized, immunomodulating |
